SUN-LB056 The Pharmacological Blockade of the Splicing Factor SF3B1 Exerts Antitumor Actions in Different Endocrine-Related Cancers

The intrinsic heterogeneity of endocrine-related cancers (ERCs) hampers the identification and development of global and effective therapeutic treatments for these pathologies. However, the dysregulation of the splicing process has been postulated as a new common hallmark shared by most cancer types...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Endocr Soc
Prif Awduron: Gahete, Manuel, Jiménez-Vacas, Juan, Lopez-Canovas, Juan, Vazquez-Borrego, Mari, Pedraza-Arevalo, Sergio, del Río-Moreno, Mercedes, Herrero-Aguayo, Vicente, Saez-Martinez, Prudencio, Montero-Hidalgo, Antonio, Blazquez-Encinas, Ricardo, Lara-Lopez, Araceli, Pérez-Gómez, Jesus, Gomez-Gomez, Enrique, Herrera-Martínez, Aura, Soto-Moreno, Alfonso, Castano, Justo, Luque, Raul
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Endocrine Society 2019
Pynciau:
Tumor Biology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552932/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-LB056
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg